Please select the option that best describes you:
What factors aside from progression do you consider most important in determining whether a patient with metastatic papillary thyroid carcinoma is radioactive iodine refractory?
What is your evaluation approach for RAI response? What cumulative dose do you use in practice for deciding a patient is RAI refractory?
Answer from: at Community Practice
RAI refractory or resistant is defined as:
Progression despite adequate RAI RX within the prior year after therapy
Tumor that does not take up RAI either on a diagnostic or post-therapy whole body scan
Sign in or Register to read more